DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

The Big Pharma is paying 3SBio $1.25 billion upfront for ex-China rights to a clinical candidate, establishing itself as a challenger to BioNTech, Merck & Co. and Summit Therapeutics in a ...

Scientists in India may have found a cheaper and safer option with their new sodium-ion batteries. A research team at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), an ...

Center for Synaptic Neuroscience and Technology (NSYN@UniGe), Istituto Italiano di Tecnologia, Largo Rosanna Benzi 10, 16132 Genova, Italy IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi ...

Merck, known as MSD outside of the United States and Canada, announced that the phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, met its primary endpoint of progression-free survival (PFS) for the ...

Semiconductor Materials Growth: 2% increase. Equity Ratio: Strengthened from 58% to 61%. Merck KGaA (MKGAF) achieved profitable growth across all three business sectors in Q1 2025, with group ...

Germany’s Merck MRK-0.13%decrease; red down pointing triangle KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange ...